Status:
COMPLETED
Association of MPOD Values With Blue Light.
Lead Sponsor:
The University of Queensland
Conditions:
Age Related Macular Degeneration
Eligibility:
All Genders
18-65 years
Brief Summary
This study aims to investigate in healthy adults 18-65 years of age the association of electronic device blue light exposure and macular pigment optical density (MPOD) considering usual dietary intake...
Detailed Description
Exponential uptake of modern technology over the last 30 years (computers) and 10 years (smartphones) has resulted in remarkable increase in artificial blue light exposure amongst all age groups. This...
Eligibility Criteria
Inclusion
- Male and females 18 to 65 years.
- Generally healthy.
- No participant reported history of clinically significant medical conditions including, but not limited to, cardiovascular, neurological, psychiatric, renal, immunological, endocrine (including uncontrolled diabetes or thyroid disease) or haematological abnormalities that are uncontrolled.
- Non-smoker
Exclusion
- Participant reported diagnosis of serious ocular conditions (e.g. cataracts, glaucoma, diabetic retinopathy, retinitis pigmentosa, Stagardt's disease)
- Participant reported diagnosis, or current treatment of age-related macular degeneration.
- Participant reported diagnosis of epilepsy.
- Current or past smoker (within last 12 months).
- Under 18 or over 65 years of age.
Key Trial Info
Start Date :
September 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04779398
Start Date
September 25 2020
End Date
March 31 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Human Movement and Nutrition Sciences, The University of Queensland
Saint Lucia, Queensland, Australia, 4067